Links Between the C9orf72 Repeat Expansion and Psychiatric Symptoms

AbstractPurpose of ReviewTo present recent findings on the links between theC9orf72 expansion and psychiatric impairment.Recent FindingsRepeat hexanucleotide expansions in theC9orf72 gene are a cause of familial frontotemporal dementia (FTD), amyotrophic lateral sclerosis (ALS), and the mixed phenotype, FTD-ALS. Symptomatic expansion carriers display higher rates of psychotic and other psychiatric symptoms than non-carriers. Neuroanatomical associations of these symptoms have been found in cortical and subcortical areas. Family members of symptomatic carriers have higher rates of primary neuropsychiatric disorders than control populations, and theC9orf72 expansion may contribute to this association. However, the expansion does not appear to directly cause primary psychiatric disorders.SummaryWhile there is strong evidence associating theC9orf72 expansion with psychotic symptoms in carriers and psychiatric disorders in their kindreds, the link between these two phenomena, if any, remains unclear.
Source: Current Neurology and Neuroscience Reports - Category: Neuroscience Source Type: research

Related Links:

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are two related neurodegenerative diseases that present with similar TDP-43 pathology in patient tissue. TDP-43 is an RNA-binding protein which forms aggregates in neurons of ALS and FTD patients as well as in a subset of patients diagnosed with other neurodegenerative diseases....
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Tags: Biological Sciences Source Type: research
AbstractAmyotrophic lateral sclerosis (ALS) and hereditary spastic paraplegia (HSP) are motor neuron diseases sharing clinical, pathological, and genetic similarities. While biallelicSPG7 mutations are known to cause recessively inherited HSP, heterozygousSPG7 mutations have repeatedly been identified in HSP and recently also in ALS cases. However, the frequency and clinical impact of rareSPG7 variants have not been studied in a larger ALS cohort. Here, whole-exome (WES) or targetedSPG7 sequencing was done in a cohort of 214 European ALS patients. The consequences of a splice site variant were analyzed on the mRNA level. T...
Source: Journal of Neurology - Category: Neurology Source Type: research
This case-control study examines the use of fluorine 18 –labeled fluorodeoxyglucose positron emission tomographic imaging to detect glucose metabolic changes in individuals who are presymptomatic carriers of a mutation in the C9orf72 gene that leads to amyotrophic lateral sclerosis and frontotemporal dementia.
Source: JAMA Neurology - Category: Neurology Source Type: research
This report shows compelling evidence that PPIs act as inhibitors of ChAT, with high selectivity and unprecedented potencies that lie far below their in vivo plasma and brain concentrations. DISCUSSION: Given that accumulating evidence points at cholinergic dysfunction as a driving force of major dementia disorders, our findings mechanistically explain how prolonged use of PPIs may increase incidence of dementia. This call for restrictions for prolonged use of PPIs in elderly, and in patients with dementia or amyotrophic lateral sclerosis. PMID: 32383816 [PubMed - as supplied by publisher]
Source: The Journal of Alzheimers Association - Category: Psychiatry Tags: Alzheimers Dement Source Type: research
(Emory Health Sciences) Insight into the pathological mechanisms behind two devastating neurodegenerative diseases: the most common inherited form of amyotrophic lateral sclerosis/ frontotemporal dementia (ALS/FTD) and spinocerebellar ataxia type 36 (SCA36). Expanded repeats lead to peptide gobbledygook in both, but with critical differences.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
A massive intronic hexanucleotide repeat (GGGGCC) expansion in C9ORF72 is a genetic origin of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Recently, C9ORF72, together with SMCR8 and WDR41, has been shown to regulate autophagy and function as Rab GEF. However, the precise function of C9ORF72 remains unclear. Here, we...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Tags: Biological Sciences Source Type: research
In this study, we report that RBPs increased significantly compared with the sham group (*p
Source: Brain Research - Category: Neurology Authors: Tags: Brain Res Source Type: research
.
Source: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration - Category: Neurology Authors: Source Type: research
by Yon Ju Ji, Janet Ugolino, Tao Zhang, Jiayin Lu, Dohoon Kim, Jiou Wang Nutrient utilization and energy metabolism are critical for the maintenance of cellular homeostasis. A mutation in theC9orf72 gene has been linked to the most common forms of neurodegenerative diseases that include amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Here we have identified an evolutionarily conserved function of C9orf72 in the regulation of the transcription factor EB (TFEB), a master regulator of autophagic and lysosomal genes that is negatively modulated by mTORC1. Loss of theC.elegans orthologue of C9orf72, ALFA...
Source: PLoS Genetics - Category: Genetics & Stem Cells Authors: Source Type: research
We describe methods to validate repeat expansion cloning, including diagnostic restriction digestion, PCR across the repeat, and next-generation long-read MinION nanopore sequencing. Validated cloning of microsatellite repeats beyond the critical expansion threshold can facilitate step-by-step characterization of disease mechanisms at the cellular and molecular level.
Source: Human Genetics - Category: Genetics & Stem Cells Source Type: research
More News: ALS | Brain | Dementia | Genetics | Neurology | Neuroscience | Psychiatry